Prevalence of metabolic syndrome and metabolic dysfunction-associated fatty liver disease in Malaysia 2023: study protocol for a community-based nationwide cross-sectional survey
Key result
This study protocol describes a planned nationwide cross-sectional survey to determine the prevalence of metabolic syndrome and MAFLD among 1,296 adults in Malaysia; results are pending.
Why the study?
People with MetS or MAFLD face higher risks for adverse cardiovascular outcomes and mortalities, but large-scale prevalence data in Malaysia are largely unknown.
Population
Planned sample size of 1296 general adult population participants in Malaysia
Design
Community-based nationwide cross-sectional study
Authors
Discussion
Loading...
Member takes
Implication
Nationwide MetS and MAFLD prevalence data may guide screening; leaves open longitudinal cardiovascular outcome associations.
Study Design
Type
Cross-Sectional (n=1,296)
Multicenter
Yes
Structured PICO
P
Population
A planned nationwide cross-sectional study of 1,296 adults in Malaysia to determine the prevalence of metabolic syndrome and metabolic dysfunction-associated fatty liver disease.
O
Outcome
Prevalence of metabolic syndrome (MetS) and metabolic dysfunction-associated fatty liver disease (MAFLD)
This study protocol outlines a nationwide cross-sectional survey to determine the prevalence of metabolic syndrome and MAFLD in Malaysia.
Cite This Study
Wan et al. (2023) conducted a cross-sectional in Metabolic syndrome and metabolic dysfunction-associated fatty liver disease (n=1,296). Metabolic syndrome and MAFLD was evaluated on Prevalence of MetS and MAFLD. This study protocol describes a planned nationwide cross-sectional survey to determine the prevalence of metabolic syndrome and MAFLD among 1,296 adults in Malaysia; results are pending.